October 11, 2016 / 2:21 PM / 9 months ago

BRIEF-Delcath Systems announces new clinical sites for FOCUS Phase 3 trial for ocular melanoma liver metastases

1 Min Read

Oct 11 (Reuters) - Delcath Systems Inc

* Delcath Systems - 5 new clinical trial sites in U.S. have been activated in global FOCUS Phase 3 clinical trial for ocular melanoma liver metastases

* Currently, Delcath now has a total of 8 cancer centers in U.S. open for patient enrollment in FOCUS trial Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below